Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]
Clinical trial update on memory T-cell infusion after TCR-alpha/beta depleted hematopoietic stem cell transplantation, with Phase 1/2 status…
-
CLINICAL_TRIALS research · 2016-04-20Clinical Trial Update: Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia [Phase 3]
A Phase 3 clinical trial update evaluating recombinant human thrombopoietin (rhTPO) for chemotherapy-induced thrombocytopenia in patients wi…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: TevaGastrim for Stem Cell Mobilization Sibling Donors [Phase 2]
This Phase 2 clinical trial update reports the completion of a study evaluating TevaGastrim for stem cell mobilization in sibling donors for…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer [Phase 1]
A Phase I clinical trial is evaluating an oncofetal antigen multi-peptide immunotherapy in hematologic cancers, including acute myeloid leuk…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome [Phase 1]
Phase 1 trial testing belinostat and bortezomib in relapsed or refractory acute leukemias and myelodysplastic syndrome has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-04-15Clinical Trial Update: S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy
This entry reports on the S0106A trial, a biomarker study in patients with newly diagnosed acute myeloid leukemia treated with cytarabine-ba…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia
This SWOG clinical trial update reports a completed study investigating DNA analyses in samples from patients with acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia [Phase 1]
A Phase 1 study evaluating LOP628 in adults with c-KIT–positive solid tumors and acute myeloid leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML) [Phase 3]
This clinical trial update summarizes a Phase 3 study evaluating remission-induction therapy followed by a risk-oriented postremission strat…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
Phase 1/2 trial examining idarubicin + cytarabine with lenalidomide for myelodysplastic syndrome and acute myeloid leukemia has completed wi…
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia [Phase 1, Phase 2]
Clinical trial update indicates that the Phase 1/2 safety study of AKN-028 in Acute Myeloid Leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL [Phase 1, Phase 2]
A phase 1/2 trial evaluating an allogeneic stem cell transplant regimen using clofarabine, cytarabine (Ara-C), and total body irradiation fo…
-
CLINICAL_TRIALS research · 2016-03-23Clinical Trial Update: Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia
This clinical trial update investigates the prognostic value of minimal residual disease in acute myeloid leukemia and notes the study as co…
-
CLINICAL_TRIALS trial_result · 2016-03-18Clinical Trial Update: VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating pre-emptive azacitidine and donor lymphocyte infusions after allogeneic stem cell transplantation for high-risk acu…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Lenalidomide Plus Chemotherapy for AML [Phase 1]
A Phase 1 trial evaluating lenalidomide in combination with chemotherapy for acute myeloid leukemia has been completed.
-
FDA approval · 2016-03-16FDA Approved: DECITABINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Decitabine filed by Sun Pharmaceutical Industries, Inc. The approval updates the product's label…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR) [Phase 2]
This update summarizes results from a Phase 2 trial evaluating maintenance therapy in elderly patients with acute myeloid leukemia after ach…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia [Phase 1]
Phase 1 study of Plerixafor plus Granulocyte-colony Stimulating Factor in relapsed Acute Myeloid Leukemia was terminated. The trial status i…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients [Phase 1]
Phase I study of CWP232291 in patients with acute myeloid leukemia and related myeloid neoplasms has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice
Clinical trial update on the use of decitabine for chemotherapy-unfit elderly patients with acute myeloid leukemia in real-world Korean prac…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies [Phase 2]
Phase 2 trial of Brentuximab Vedotin in CD30-positive non-lymphomatous malignancies has completed and results were posted in 2016. The study…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649) [Phase 1]
Phase 1 trial of MK-8242 alone and with cytarabine in adults with acute myeloid leukemia (AML) was terminated; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma [Phase 1]
Phase 1 trial of a cancer vaccine therapy with GM-CSF in patients with acute myeloid leukemia, myelodysplastic syndromes, non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Dasatinib (Sprycel™) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
This update reports the completion of Phase 1 and Phase 2 clinical trials evaluating dasatinib (Sprycel) in newly diagnosed core-binding fac…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 trial evaluating clofarabine with low-dose cytarabine induction followed by decitabine consolidation in frontline acute myeloid leuk…